ITVR20100140A1 - Materiale composito formato da pectina e da calcio fosfato e metodo per la sua realizzazione - Google Patents
Materiale composito formato da pectina e da calcio fosfato e metodo per la sua realizzazione Download PDFInfo
- Publication number
- ITVR20100140A1 ITVR20100140A1 IT000140A ITVR20100140A ITVR20100140A1 IT VR20100140 A1 ITVR20100140 A1 IT VR20100140A1 IT 000140 A IT000140 A IT 000140A IT VR20100140 A ITVR20100140 A IT VR20100140A IT VR20100140 A1 ITVR20100140 A1 IT VR20100140A1
- Authority
- IT
- Italy
- Prior art keywords
- calcium
- solution
- phosphate
- pectin
- calcium phosphate
- Prior art date
Links
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 title claims description 81
- 239000001506 calcium phosphate Substances 0.000 title claims description 79
- 235000011010 calcium phosphates Nutrition 0.000 title claims description 76
- 235000010987 pectin Nutrition 0.000 title claims description 76
- 239000001814 pectin Substances 0.000 title claims description 76
- 229920001277 pectin Polymers 0.000 title claims description 76
- 229910000389 calcium phosphate Inorganic materials 0.000 title claims description 62
- 239000002131 composite material Substances 0.000 title claims description 59
- 238000000034 method Methods 0.000 title claims description 39
- 229960001714 calcium phosphate Drugs 0.000 claims description 54
- 239000000243 solution Substances 0.000 claims description 51
- 239000000725 suspension Substances 0.000 claims description 24
- 238000002156 mixing Methods 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 238000004132 cross linking Methods 0.000 claims description 12
- 230000007547 defect Effects 0.000 claims description 11
- 239000011575 calcium Substances 0.000 claims description 10
- 230000032050 esterification Effects 0.000 claims description 9
- 238000005886 esterification reaction Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 8
- 229960005069 calcium Drugs 0.000 claims description 8
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 235000019691 monocalcium phosphate Nutrition 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 5
- 210000000845 cartilage Anatomy 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 5
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 5
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 5
- 239000000316 bone substitute Substances 0.000 claims description 4
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 claims description 4
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 claims description 4
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 4
- 231100000444 skin lesion Toxicity 0.000 claims description 4
- 206010040882 skin lesion Diseases 0.000 claims description 4
- 239000001736 Calcium glycerylphosphate Substances 0.000 claims description 3
- 229940095618 calcium glycerophosphate Drugs 0.000 claims description 3
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 claims description 3
- 235000019299 calcium glycerylphosphate Nutrition 0.000 claims description 3
- LLEWEKKNPYGRTD-UHFFFAOYSA-L calcium;2-hydroxypropanoyl phosphate Chemical compound [Ca+2].CC(O)C(=O)OP([O-])([O-])=O LLEWEKKNPYGRTD-UHFFFAOYSA-L 0.000 claims description 3
- PBUBJNYXWIDFMU-UHFFFAOYSA-L calcium;butanedioate Chemical compound [Ca+2].[O-]C(=O)CCC([O-])=O PBUBJNYXWIDFMU-UHFFFAOYSA-L 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 claims description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 3
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- -1 calcium-ophosphate Chemical compound 0.000 claims description 2
- HHSPVTKDOHQBKF-UHFFFAOYSA-J calcium;magnesium;dicarbonate Chemical compound [Mg+2].[Ca+2].[O-]C([O-])=O.[O-]C([O-])=O HHSPVTKDOHQBKF-UHFFFAOYSA-J 0.000 claims description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 claims 2
- 229940043256 calcium pyrophosphate Drugs 0.000 claims 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 claims 2
- 239000004135 Bone phosphate Substances 0.000 claims 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims 1
- 239000001095 magnesium carbonate Substances 0.000 claims 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000000499 gel Substances 0.000 description 27
- 239000000463 material Substances 0.000 description 26
- 230000008901 benefit Effects 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 239000001110 calcium chloride Substances 0.000 description 5
- 229910001628 calcium chloride Inorganic materials 0.000 description 5
- 235000011148 calcium chloride Nutrition 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 238000003760 magnetic stirring Methods 0.000 description 4
- 150000004804 polysaccharides Chemical class 0.000 description 4
- 238000004566 IR spectroscopy Methods 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000003416 augmentation Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 244000248349 Citrus limon Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000002805 bone matrix Anatomy 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 230000003239 periodontal effect Effects 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 208000017234 Bone cyst Diseases 0.000 description 1
- 206010061728 Bone lesion Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000000588 acetabulum Anatomy 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229920001586 anionic polysaccharide Polymers 0.000 description 1
- 150000004836 anionic polysaccharides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000011882 arthroplasty Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 210000000459 calcaneus Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000002683 hand surgery Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 210000002758 humerus Anatomy 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004086 maxillary sinus Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000004492 methyl ester group Chemical group 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000000278 osteoconductive effect Effects 0.000 description 1
- 230000002642 osteogeneic effect Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- YSJNWPJHMDWGAA-UHFFFAOYSA-H tricalcium;[oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O YSJNWPJHMDWGAA-UHFFFAOYSA-H 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
- A61L27/425—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/06—Pectin; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Medicinal Preparation (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000140A ITVR20100140A1 (it) | 2010-07-13 | 2010-07-13 | Materiale composito formato da pectina e da calcio fosfato e metodo per la sua realizzazione |
EP11749918.6A EP2593149B1 (de) | 2010-07-13 | 2011-07-13 | Verbundstoff mit pectin und calciumphosphat sowie verfahren zu seiner herstellung |
PCT/IB2011/053136 WO2012007917A2 (en) | 2010-07-13 | 2011-07-13 | Composite material comprising pectin and calcium phosphate and method for its realisation |
US13/809,855 US9066934B2 (en) | 2010-07-13 | 2011-07-13 | Composite material comprising pectin and calcium phosphate and method for its realisation |
BR112013000896A BR112013000896B8 (pt) | 2010-07-13 | 2011-07-13 | Material composto compreendendo pectina e fosfato de cálcio e método para sua realização |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000140A ITVR20100140A1 (it) | 2010-07-13 | 2010-07-13 | Materiale composito formato da pectina e da calcio fosfato e metodo per la sua realizzazione |
Publications (1)
Publication Number | Publication Date |
---|---|
ITVR20100140A1 true ITVR20100140A1 (it) | 2012-01-14 |
Family
ID=43532813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT000140A ITVR20100140A1 (it) | 2010-07-13 | 2010-07-13 | Materiale composito formato da pectina e da calcio fosfato e metodo per la sua realizzazione |
Country Status (5)
Country | Link |
---|---|
US (1) | US9066934B2 (de) |
EP (1) | EP2593149B1 (de) |
BR (1) | BR112013000896B8 (de) |
IT (1) | ITVR20100140A1 (de) |
WO (1) | WO2012007917A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITVR20120045A1 (it) * | 2012-03-14 | 2013-09-15 | Eurocoating S P A | Metodo per la realizzazione di un impianto osseo biocompatibile comprendente elementi granulari ed un gel biopolimerico bioriassorbibile e impianto oseeo biocompatibile ottenuto con tale metodo. |
CN114538914A (zh) * | 2022-03-14 | 2022-05-27 | 成都理工大学 | 一种具有抗菌功能的锌掺杂磷酸钙陶瓷微球及制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4103876A1 (de) * | 1990-02-09 | 1991-08-14 | Asahi Optical Co Ltd | Verfahren zur fixierung einer koernigen knochen-prothese |
US5980625A (en) * | 1997-03-13 | 1999-11-09 | Ngk Spark Plug Co., Ltd. | Calcium phosphate composition and a setting solution therefor |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2708404A1 (de) * | 1977-02-26 | 1978-08-31 | Herbstreith Pektinfab | Verfahren zur herstellung eines pektinderivates, insbesondere auf der basis von obstpektin, und zur herstellung eines nahrungsmittel-gelierstoffes und nahrungsmittel-gelierstoff |
US7494669B2 (en) * | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
US8083851B2 (en) * | 2006-12-29 | 2011-12-27 | Sciessent Llc | Antimicrobial cements and cementitious compositions |
-
2010
- 2010-07-13 IT IT000140A patent/ITVR20100140A1/it unknown
-
2011
- 2011-07-13 EP EP11749918.6A patent/EP2593149B1/de active Active
- 2011-07-13 BR BR112013000896A patent/BR112013000896B8/pt active IP Right Grant
- 2011-07-13 US US13/809,855 patent/US9066934B2/en active Active
- 2011-07-13 WO PCT/IB2011/053136 patent/WO2012007917A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4103876A1 (de) * | 1990-02-09 | 1991-08-14 | Asahi Optical Co Ltd | Verfahren zur fixierung einer koernigen knochen-prothese |
US5980625A (en) * | 1997-03-13 | 1999-11-09 | Ngk Spark Plug Co., Ltd. | Calcium phosphate composition and a setting solution therefor |
Non-Patent Citations (1)
Title |
---|
GIROD FULLANA S ET AL: "Controlled release properties and final macroporosity of a pectin microspheres@?calcium phosphate composite bone cement", ACTA BIOMATERIALIA, ELSEVIER, AMSTERDAM, NL, vol. 6, no. 6, 1 June 2010 (2010-06-01), pages 2294 - 2300, XP027035750, ISSN: 1742-7061, [retrieved on 20091204] * |
Also Published As
Publication number | Publication date |
---|---|
US20130177656A1 (en) | 2013-07-11 |
BR112013000896B8 (pt) | 2023-02-28 |
EP2593149B1 (de) | 2014-04-30 |
BR112013000896A2 (pt) | 2016-05-24 |
US9066934B2 (en) | 2015-06-30 |
EP2593149A2 (de) | 2013-05-22 |
BR112013000896B1 (pt) | 2019-04-24 |
WO2012007917A2 (en) | 2012-01-19 |
WO2012007917A3 (en) | 2012-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bigi et al. | Effect of added gelatin on the properties of calcium phosphate cement | |
Sivakumar et al. | Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite–gelatin composite microspheres | |
CA2661548C (en) | Macroporous and highly resorbable apatitic calcium-phosphate cement | |
DK2403547T3 (en) | MANUFACTURING FORMABLE BONE COMPENSATION | |
CN102526798B (zh) | 可注射复合骨水泥及其制备方法 | |
Alves Cardoso et al. | Gelation and biocompatibility of injectable Alginate–Calcium phosphate gels for bone regeneration | |
Ambrosio et al. | Injectable calcium-phosphate-based composites for skeletal bone treatments | |
Amirian et al. | Incorporation of alginate-hyaluronic acid microbeads in injectable calcium phosphate cement for improved bone regeneration | |
CN103800946A (zh) | 矿化胶原复合骨粘合及填充材料 | |
EP3031478B1 (de) | Knochenregenerationsmaterialkit, pastöses knochenregenerationsmaterial, knochenregenerationsmaterial und knochenbindungsmaterial | |
EP2600912B1 (de) | Selbstausdehnender biopolymer-mineral-verbundstoff | |
CN114470320A (zh) | 一种骨粘接剂、其制备方法及应用 | |
Dou et al. | Highly elastic and self-healing nanostructured gelatin/clay colloidal gels with osteogenic capacity for minimally invasive and customized bone regeneration | |
Rattanachan et al. | Development of injectable chitosan/biphasic calcium phosphate bone cement and in vitro and in vivo evaluation | |
Mao et al. | Preparation and properties of α-calcium sulphate hemihydrate and β-tricalcium phosphate bone substitute | |
RU2494721C1 (ru) | Биосовместимый костнозамещающий материал и способ получения его | |
ITVR20100140A1 (it) | Materiale composito formato da pectina e da calcio fosfato e metodo per la sua realizzazione | |
ES2357191T3 (es) | Material compuesto poroso, correspondiente proceso de preparación y su uso para realizar dispositivo para ingeniería tisular. | |
Dabbarh et al. | Chitosan based biocomposites for hard tissue engineering | |
AU6127400A (en) | Composites | |
JP7412700B2 (ja) | 多孔質複合体 | |
Bongio et al. | Development of an in vitro confinement test to predict the clinical handling of polymer-based injectable bone substitutes | |
Pan et al. | Assessment of the suitability of a new composite as a bone defect filler in a rabbit model | |
US9066969B2 (en) | Ceramic biocomposite for bone regeneration | |
Luomala | In vitro Characterization of Covalently Photo-Crosslinked Polymer/Bioactive Glass Hybrid for Bone Tissue Engineering |